Narrative Testimony and Characteristics of Rottlerin for the Treatment of Various Kinds of Cancer

IF 0.4 Q4 ONCOLOGY
Lopamudra Mishra, Lakshmi Kumari, Preeti Patel, Amrita Singh, Balak Das Kurmi
{"title":"Narrative Testimony and Characteristics of Rottlerin for the Treatment of Various Kinds of Cancer","authors":"Lopamudra Mishra, Lakshmi Kumari, Preeti Patel, Amrita Singh, Balak Das Kurmi","doi":"10.2174/0115733947244863230928095352","DOIUrl":null,"url":null,"abstract":"From ancient times until now, scientists have focused on herbal medicaments for treating various diseases. Rottlerin, a potent PKCδ inhibitor, is one of the greatest herbal medications. Over the years, it was identified that rottlerin has several cellular and molecular targets that could be involved in the fight against cancer. The past and present research has clearly shown that rottlerin inhibits the transcription factors, enzymes, and signaling molecules that regulate the death and life of cancer cells. Although the anticancer property of rottlerin has primarily been attributed to the induction of autophagy and apoptosis, current research has revealed the existence of different damage pathways. The major part described in this mini-review is the antitumor/anticancer effects of rottlerin in various organs of the human body affected by breast cancer, pancreatic cell cancer, bladder cancer, NSCLC, prostate cancer, ovarian cancer, nasopharyngeal cancer, etc.","PeriodicalId":43754,"journal":{"name":"Current Cancer Therapy Reviews","volume":"2 1","pages":"0"},"PeriodicalIF":0.4000,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cancer Therapy Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115733947244863230928095352","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

From ancient times until now, scientists have focused on herbal medicaments for treating various diseases. Rottlerin, a potent PKCδ inhibitor, is one of the greatest herbal medications. Over the years, it was identified that rottlerin has several cellular and molecular targets that could be involved in the fight against cancer. The past and present research has clearly shown that rottlerin inhibits the transcription factors, enzymes, and signaling molecules that regulate the death and life of cancer cells. Although the anticancer property of rottlerin has primarily been attributed to the induction of autophagy and apoptosis, current research has revealed the existence of different damage pathways. The major part described in this mini-review is the antitumor/anticancer effects of rottlerin in various organs of the human body affected by breast cancer, pancreatic cell cancer, bladder cancer, NSCLC, prostate cancer, ovarian cancer, nasopharyngeal cancer, etc.
罗特勒林治疗各类肿瘤的叙事证据及特点
从古至今,科学家们一直致力于用草药来治疗各种疾病。Rottlerin是一种有效的PKCδ抑制剂,是最好的草药之一。多年来,人们已经确定,rotlerin有几个细胞和分子靶标,可以参与对抗癌症。过去和现在的研究都清楚地表明,rotlerin能够抑制调控癌细胞生死的转录因子、酶和信号分子。虽然rotlerin的抗癌特性主要归因于诱导自噬和凋亡,但目前的研究表明存在不同的损伤途径。在这篇综述中主要描述的是rotlerin在乳腺癌、胰腺癌、膀胱癌、非小细胞肺癌、前列腺癌、卵巢癌、鼻咽癌等影响人体各器官的抗肿瘤/抗癌作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
50
期刊介绍: Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信